| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.2M | -90.6% |
| R&D Expense | $98.4M | +5.7% |
| SG&A Expense | $38.1M | +3.5% |
| Operating Income | -$133.3M | -38.9% |
| Pre-tax Income | $1.2M | +101.3% |
| Income Tax | $715K | — |
| Net Income | -$5.0M | +94.8% |
| EPS (Basic) | -$0.09 | +94.8% |
| EPS (Diluted) | -$0.09 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $34.0M | -68.6% |
| Current Assets | $181.0M | -5.7% |
| Total Assets | $228.5M | +7.9% |
| Current Liabilities | $22.6M | +31.1% |
| Total Liabilities | $50.5M | +20.0% |
| Stockholders' Equity | $178.0M | +4.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$113.7M | -3.6% |
| Capital Expenditures | $1.3M | -46.4% |
| Investing Cash Flow | $36.7M | +172.3% |
| Financing Cash Flow | $596K | -98.9% |
| Free Cash Flow | -$114.9M | -2.5% |
| +94.8% |